DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Schema
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://www.nature.com/articles/nature04809, but it redirected us to https://www.nature.com/articles/nature04809. The analysis below is for the second page.

Title[redir]:
Identification of a tumour suppressor network opposing nuclear Akt function | Nature
Description:
The proto-oncogene AKT (also known as PKB) is activated in many human cancers, mostly owing to loss of the PTEN tumour suppressor1. In such tumours, AKT becomes enriched at cell membranes where it is activated by phosphorylation. Yet many targets inhibited by phosphorylated AKT (for example, the FOXO transcription factors) are nuclear; it has remained unclear how relevant nuclear phosphorylated AKT (pAKT) function is for tumorigenesis. Here we show that the PMLtumour suppressor prevents cancer by inactivating pAKT inside the nucleus. We find in a mouse model that Pml loss markedly accelerates tumour onset, incidence and progression in Pten-heterozygous mutants, and leads to female sterility with features that recapitulate the phenotype of Foxo3a knockout mice2. We show that Pml deficiency on its own leads to tumorigenesis in the prostate, a tissue that is exquisitely sensitive to pAkt levels, and demonstrate that Pml specifically recruits the Akt phosphatase PP2a as well as pAkt into Pml nuclear bodies. Notably, we find that Pml-null cells are impaired in PP2a phosphatase activity towards Akt, and thus accumulate nuclear pAkt. As a consequence, the progressive reduction in Pml dose leads to inactivation of Foxo3a-mediated transcription of proapoptotic Bim and the cell cycle inhibitor p27kip1. Our results demonstrate that Pml orchestrates a nuclear tumour suppressor network for inactivation of nuclear pAkt, and thus highlight the importance of AKT compartmentalization in human cancer pathogenesis and treatment.

Matching Content Categories {📚}

Telecommunications
Science
Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

article, pubmed, google, scholar, cas, nature, cell, cancer, akt, pml, suppressor, nuclear, pten, access, tumor, content, tumour, pier, paolo, pandolfi, prostate, regulation, cookies, function, data, transcription, pakt, mice, suppression, ads, privacy, information, trotman, ppa, sci, central, essential, alimonti, scaglioni, cordoncardo, human, tumorigenesis, leads, phosphatase, multiple, genet, biol, science, protein, ppp,

Topics {✒️}

nature portfolio privacy policy permissions reprints nature cell biol advertising pkb/akt-dependent cell survival social media embryonic development p53-dependent cellular senescence subscribe nature nature genet pml-ii regulates erk high cancer susceptibility nature 436 nature nature 441 author information authors pier paolo pandolfi pier paolo scaglioni p53-dependent apoptosis springerlink instant access author contributions author correspondence permissions information akt signal activation expected tumor suppressor tumour suppressor pml sloan-kettering institute tumor suppressor pten ovarian follicle activation competing financial interests personal data stress-dependent regulation pten tumour suppressor1 privacy suppresses tumor growth metastatic prostate cancer prostate cancer cells pml nuclear bodies permissions proto-oncogene akt pi3k–akt pathway directly dephosphorylates akt pten-deficient tumorigenesis data protection data analysis akt phosphatase pp2a accumulate nuclear pakt cordon-cardo prostate-specific deletion

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Identification of a tumour suppressor network opposing nuclear Akt function
         description:The proto-oncogene AKT (also known as PKB) is activated in many human cancers, mostly owing to loss of the PTEN tumour suppressor1. In such tumours, AKT becomes enriched at cell membranes where it is activated by phosphorylation. Yet many targets inhibited by phosphorylated AKT (for example, the FOXO transcription factors) are nuclear; it has remained unclear how relevant nuclear phosphorylated AKT (pAKT) function is for tumorigenesis. Here we show that the PMLtumour suppressor prevents cancer by inactivating pAKT inside the nucleus. We find in a mouse model that Pml loss markedly accelerates tumour onset, incidence and progression in Pten-heterozygous mutants, and leads to female sterility with features that recapitulate the phenotype of Foxo3a knockout mice2. We show that Pml deficiency on its own leads to tumorigenesis in the prostate, a tissue that is exquisitely sensitive to pAkt levels, and demonstrate that Pml specifically recruits the Akt phosphatase PP2a as well as pAkt into Pml nuclear bodies. Notably, we find that Pml-null cells are impaired in PP2a phosphatase activity towards Akt, and thus accumulate nuclear pAkt. As a consequence, the progressive reduction in Pml dose leads to inactivation of Foxo3a-mediated transcription of proapoptotic Bim and the cell cycle inhibitor p27kip1. Our results demonstrate that Pml orchestrates a nuclear tumour suppressor network for inactivation of nuclear pAkt, and thus highlight the importance of AKT compartmentalization in human cancer pathogenesis and treatment.
         datePublished:2006-05-07T00:00:00Z
         dateModified:2006-05-07T00:00:00Z
         pageStart:523
         pageEnd:527
         sameAs:https://doi.org/10.1038/nature04809
         keywords:
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature04809/MediaObjects/41586_2006_Article_BFnature04809_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature04809/MediaObjects/41586_2006_Article_BFnature04809_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature04809/MediaObjects/41586_2006_Article_BFnature04809_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature04809/MediaObjects/41586_2006_Article_BFnature04809_Fig4_HTML.jpg
         isPartOf:
            name:Nature
            issn:
               1476-4687
               0028-0836
            volumeNumber:441
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Lloyd C. Trotman
               affiliation:
                     name:Cancer Biology and Genetics Program
                     address:
                        name:Cancer Biology and Genetics Program,
                        type:PostalAddress
                     type:Organization
                     name:Department of Pathology
                     address:
                        name:Department of Pathology,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andrea Alimonti
               affiliation:
                     name:Cancer Biology and Genetics Program
                     address:
                        name:Cancer Biology and Genetics Program,
                        type:PostalAddress
                     type:Organization
                     name:Department of Pathology
                     address:
                        name:Department of Pathology,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pier Paolo Scaglioni
               affiliation:
                     name:Cancer Biology and Genetics Program
                     address:
                        name:Cancer Biology and Genetics Program,
                        type:PostalAddress
                     type:Organization
                     name:Department of Medicine
                     address:
                        name:Department of Medicine,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jason A. Koutcher
               affiliation:
                     name:Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute
                     address:
                        name:Departments of Medicine, Radiology and Medical Physics, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carlos Cordon-Cardo
               affiliation:
                     name:Department of Pathology
                     address:
                        name:Department of Pathology,
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pier Paolo Pandolfi
               affiliation:
                     name:Cancer Biology and Genetics Program
                     address:
                        name:Cancer Biology and Genetics Program,
                        type:PostalAddress
                     type:Organization
                     name:Department of Pathology
                     address:
                        name:Department of Pathology,
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Identification of a tumour suppressor network opposing nuclear Akt function
      description:The proto-oncogene AKT (also known as PKB) is activated in many human cancers, mostly owing to loss of the PTEN tumour suppressor1. In such tumours, AKT becomes enriched at cell membranes where it is activated by phosphorylation. Yet many targets inhibited by phosphorylated AKT (for example, the FOXO transcription factors) are nuclear; it has remained unclear how relevant nuclear phosphorylated AKT (pAKT) function is for tumorigenesis. Here we show that the PMLtumour suppressor prevents cancer by inactivating pAKT inside the nucleus. We find in a mouse model that Pml loss markedly accelerates tumour onset, incidence and progression in Pten-heterozygous mutants, and leads to female sterility with features that recapitulate the phenotype of Foxo3a knockout mice2. We show that Pml deficiency on its own leads to tumorigenesis in the prostate, a tissue that is exquisitely sensitive to pAkt levels, and demonstrate that Pml specifically recruits the Akt phosphatase PP2a as well as pAkt into Pml nuclear bodies. Notably, we find that Pml-null cells are impaired in PP2a phosphatase activity towards Akt, and thus accumulate nuclear pAkt. As a consequence, the progressive reduction in Pml dose leads to inactivation of Foxo3a-mediated transcription of proapoptotic Bim and the cell cycle inhibitor p27kip1. Our results demonstrate that Pml orchestrates a nuclear tumour suppressor network for inactivation of nuclear pAkt, and thus highlight the importance of AKT compartmentalization in human cancer pathogenesis and treatment.
      datePublished:2006-05-07T00:00:00Z
      dateModified:2006-05-07T00:00:00Z
      pageStart:523
      pageEnd:527
      sameAs:https://doi.org/10.1038/nature04809
      keywords:
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature04809/MediaObjects/41586_2006_Article_BFnature04809_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature04809/MediaObjects/41586_2006_Article_BFnature04809_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature04809/MediaObjects/41586_2006_Article_BFnature04809_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature04809/MediaObjects/41586_2006_Article_BFnature04809_Fig4_HTML.jpg
      isPartOf:
         name:Nature
         issn:
            1476-4687
            0028-0836
         volumeNumber:441
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Lloyd C. Trotman
            affiliation:
                  name:Cancer Biology and Genetics Program
                  address:
                     name:Cancer Biology and Genetics Program,
                     type:PostalAddress
                  type:Organization
                  name:Department of Pathology
                  address:
                     name:Department of Pathology,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andrea Alimonti
            affiliation:
                  name:Cancer Biology and Genetics Program
                  address:
                     name:Cancer Biology and Genetics Program,
                     type:PostalAddress
                  type:Organization
                  name:Department of Pathology
                  address:
                     name:Department of Pathology,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pier Paolo Scaglioni
            affiliation:
                  name:Cancer Biology and Genetics Program
                  address:
                     name:Cancer Biology and Genetics Program,
                     type:PostalAddress
                  type:Organization
                  name:Department of Medicine
                  address:
                     name:Department of Medicine,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jason A. Koutcher
            affiliation:
                  name:Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute
                  address:
                     name:Departments of Medicine, Radiology and Medical Physics, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carlos Cordon-Cardo
            affiliation:
                  name:Department of Pathology
                  address:
                     name:Department of Pathology,
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pier Paolo Pandolfi
            affiliation:
                  name:Cancer Biology and Genetics Program
                  address:
                     name:Cancer Biology and Genetics Program,
                     type:PostalAddress
                  type:Organization
                  name:Department of Pathology
                  address:
                     name:Department of Pathology,
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature
      issn:
         1476-4687
         0028-0836
      volumeNumber:441
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Biology and Genetics Program
      address:
         name:Cancer Biology and Genetics Program,
         type:PostalAddress
      name:Department of Pathology
      address:
         name:Department of Pathology,
         type:PostalAddress
      name:Cancer Biology and Genetics Program
      address:
         name:Cancer Biology and Genetics Program,
         type:PostalAddress
      name:Department of Pathology
      address:
         name:Department of Pathology,
         type:PostalAddress
      name:Cancer Biology and Genetics Program
      address:
         name:Cancer Biology and Genetics Program,
         type:PostalAddress
      name:Department of Medicine
      address:
         name:Department of Medicine,
         type:PostalAddress
      name:Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute
      address:
         name:Departments of Medicine, Radiology and Medical Physics, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, New York, USA
         type:PostalAddress
      name:Department of Pathology
      address:
         name:Department of Pathology,
         type:PostalAddress
      name:Cancer Biology and Genetics Program
      address:
         name:Cancer Biology and Genetics Program,
         type:PostalAddress
      name:Department of Pathology
      address:
         name:Department of Pathology,
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Lloyd C. Trotman
      affiliation:
            name:Cancer Biology and Genetics Program
            address:
               name:Cancer Biology and Genetics Program,
               type:PostalAddress
            type:Organization
            name:Department of Pathology
            address:
               name:Department of Pathology,
               type:PostalAddress
            type:Organization
      name:Andrea Alimonti
      affiliation:
            name:Cancer Biology and Genetics Program
            address:
               name:Cancer Biology and Genetics Program,
               type:PostalAddress
            type:Organization
            name:Department of Pathology
            address:
               name:Department of Pathology,
               type:PostalAddress
            type:Organization
      name:Pier Paolo Scaglioni
      affiliation:
            name:Cancer Biology and Genetics Program
            address:
               name:Cancer Biology and Genetics Program,
               type:PostalAddress
            type:Organization
            name:Department of Medicine
            address:
               name:Department of Medicine,
               type:PostalAddress
            type:Organization
      name:Jason A. Koutcher
      affiliation:
            name:Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute
            address:
               name:Departments of Medicine, Radiology and Medical Physics, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, New York, USA
               type:PostalAddress
            type:Organization
      name:Carlos Cordon-Cardo
      affiliation:
            name:Department of Pathology
            address:
               name:Department of Pathology,
               type:PostalAddress
            type:Organization
      name:Pier Paolo Pandolfi
      affiliation:
            name:Cancer Biology and Genetics Program
            address:
               name:Cancer Biology and Genetics Program,
               type:PostalAddress
            type:Organization
            name:Department of Pathology
            address:
               name:Department of Pathology,
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Cancer Biology and Genetics Program,
      name:Department of Pathology,
      name:Cancer Biology and Genetics Program,
      name:Department of Pathology,
      name:Cancer Biology and Genetics Program,
      name:Department of Medicine,
      name:Departments of Medicine, Radiology and Medical Physics, Memorial Sloan-Kettering Cancer Center, Sloan-Kettering Institute, New York, USA
      name:Department of Pathology,
      name:Cancer Biology and Genetics Program,
      name:Department of Pathology,
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(2)

External Links {🔗}(230)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Prism.js
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

5.28s.